During the past decade, Andover Eye Associates conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 23 clinical trials were completed, i.e. on average, 40.4% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 18 clinical trials were completed. i.e. 72% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Andover Eye Associates" #1 sponsor was "ORA, Inc." with 8 trials, followed by "Aldeyra Therapeutics, Inc." with 6 trials sponsored, "Topcon Medical Systems, Inc." with 4 trials sponsored, "Aciex Therapeutics, Inc." with 3 trials sponsored and "Allergan" with 3 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Andover Eye Associates" #1 collaborator was "ORA, Inc." with 11 trials as a collaborator, "Statistics & Data Corporation" with 2 trials as a collaborator, "Daewoong Pharmaceutical Co. LTD." with 1 trials as a collaborator, "Palatin Technologies, Inc" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Andover Eye Associates" are "Dry Eye" (12 trials), "Allergic Conjunctivitis" (11 trials), "Dry Eye Syndromes" (9 trials), "Dry Eye Disease" (8 trials) and "Dry Eye Syndrome" (8 trials). Many other conditions were trialed in "Andover Eye Associates" in a lesser frequency.

Most popular intervention types in "Andover Eye Associates" are "Drug" (49 trials), "Device" (15 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Vehicle" (5 trials), "Reproxalap Ophthalmic Solution (0.25%)" (4 trials), "Vehicle Ophthalmic Solution" (3 trials) and "BRM421" (2 trials). Other intervention names were less common.

The vast majority of trials in "Andover Eye Associates" are 71 trials for "All" genders.

Currently, there are NaN active trials in "Andover Eye Associates". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Andover Eye Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Andover Eye Associates, 7 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 8 trials that are defined as “Not Applicable".